
Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the S&P 500.
The medical device company, known for its innovative tubeless insulin pump system, saw its stock price climb by over 24% in the past five days. This jump in Insulet’s stock price has been driven by multiple catalyst’s including a recent earnings report that exceeded analyst predictions.